NewEdge Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.31M | Buy |
11,929
+986
| +9% | +$439K | 0.03% | 548 |
|
2025
Q1 | $5.31M | Sell |
10,943
-1,708
| -14% | -$828K | 0.03% | 486 |
|
2024
Q4 | $5.09M | Buy |
12,651
+1,294
| +11% | +$521K | 0.03% | 493 |
|
2024
Q3 | $5.28M | Sell |
11,357
-2,275
| -17% | -$1.06M | 0.03% | 453 |
|
2024
Q2 | $6.39M | Buy |
13,632
+709
| +5% | +$332K | 0.05% | 370 |
|
2024
Q1 | $5.4M | Buy |
12,923
+2,619
| +25% | +$1.09M | 0.05% | 370 |
|
2023
Q4 | $4.41M | Buy |
10,304
+650
| +7% | +$278K | 0.04% | 393 |
|
2023
Q3 | $3.36M | Buy |
9,654
+1,128
| +13% | +$392K | 0.04% | 421 |
|
2023
Q2 | $3M | Buy |
8,526
+3,034
| +55% | +$1.07M | 0.03% | 456 |
|
2023
Q1 | $1.76M | Sell |
5,492
-262
| -5% | -$84.1K | 0.02% | 579 |
|
2022
Q4 | $1.47M | Sell |
5,754
-275
| -5% | -$70.4K | 0.04% | 401 |
|
2022
Q3 | $1.75M | Buy |
6,029
+1,354
| +29% | +$392K | 0.03% | 465 |
|
2022
Q2 | $1.32M | Buy |
+4,675
| New | +$1.32M | 0.02% | 565 |
|
2022
Q1 | – | Sell |
-3,863
| Closed | -$848K | – | 1640 |
|
2021
Q4 | $848K | Buy |
3,863
+2,276
| +143% | +$500K | 0.01% | 819 |
|
2021
Q3 | $288K | Sell |
1,587
-305
| -16% | -$55.4K | 0.01% | 915 |
|
2021
Q2 | $381K | Buy |
1,892
+534
| +39% | +$108K | 0.01% | 815 |
|
2021
Q1 | $292K | Sell |
1,358
-931
| -41% | -$200K | 0.01% | 822 |
|
2020
Q4 | $541K | Sell |
2,289
-13,367
| -85% | -$3.16M | 0.02% | 600 |
|
2020
Q3 | $4.26M | Buy |
15,656
+12,370
| +376% | +$3.37M | 0.15% | 145 |
|
2020
Q2 | $954K | Buy |
3,286
+1,520
| +86% | +$441K | 0.04% | 370 |
|
2020
Q1 | $420K | Buy |
1,766
+794
| +82% | +$189K | 0.02% | 503 |
|
2019
Q4 | $212K | Buy |
+972
| New | +$212K | 0.01% | 750 |
|
2019
Q2 | – | Sell |
-1,280
| Closed | -$235K | – | 705 |
|
2019
Q1 | $235K | Buy |
1,280
+30
| +2% | +$5.51K | 0.02% | 592 |
|
2018
Q4 | $207 | Buy |
+1,250
| New | +$207 | 0.01% | 577 |
|
2017
Q3 | – | Sell |
-111
| Closed | -$14.3K | – | 1108 |
|
2017
Q2 | $14.3K | Buy |
+111
| New | +$14.3K | ﹤0.01% | 836 |
|